Marker Therapeutics EPS Diluted from Tax Loss Carryforward (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.39 -0.05 (-3.47%) USD | NASDAQ | Mar 05, 16:00

1.40 +0.01 (+0.72%) After-Hours: 20:00

View EPS Diluted from Tax Loss Carryforward (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Tax Loss Carryforward (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Tax Loss Carryforward (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	--
Viridian Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Kiniksa Pharmaceuticals International Plc	--
Neurocrine Biosciences, Inc.	--